ALLEGAN, Mich., Sept. 23, 2011 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa and Senior Management will meet with analysts on Tuesday, September 27, 2011 at 8:00 a.m. (ET) at the NASDAQ MarketSite located at 4 Times Square, New York, NY.
The day will include presentations on the Consumer Healthcare, Nutritionals, Rx, and API businesses, finance, sales and marketing, quality, and research and development. Perrigo's Executive Team will be in attendance.
Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, active pharmaceutical ingredients (API) and pharmaceutical and medical diagnostic products. The Company is the world's largest store brand manufacturer of OTC pharmaceutical products and infant formulas. The Company's primary markets and locations of manufacturing and logistics operations are the United States, Israel, Mexico, the United Kingdom and Australia. Visit Perrigo on the Internet (http://www.perrigo.com).
SOURCE Perrigo Company
CONTACT: Arthur J. Shannon, Vice President, Investor Relations and Communication, +1-269-686-1709, ajshannon@perrigo.com, Bradley Joseph, Investor Relations and Communication, +1-269-686-3373, bradley.joseph@perrigo.com
Web Site: http://www.perrigo.com